Mithra Pharmaceuticals « Terug naar discussie overzicht

Mithra 2023. The Rise of the Phoenix.

2.416 Posts, Pagina: « 1 2 3 4 5 6 ... 32 33 34 35 36 37 38 39 40 41 42 ... 117 118 119 120 121 » | Laatste
[verwijderd]
0
quote:

Fagor schreef op 12 maart 2023 21:59:

-10% morgen?
Zit er dik in. De "spike up" is afgelopen.... weer met de beide beentjes op de vloer
Marc Coucke
0
En daar is de 3 al terug ;). No panic, stijging is solid, 2.4 was sowieso veel te laag voor potentieel Mithra kan bieden. Weinig goed nieuws nodig om koers naar hogere regionen te stuwen.
Sigaar en whisky
1
Het werd hier 16 graden, en de koers zit nog n eindje boven 2,5€
Ik buig het hoofd. En temperatuur en koers waren een verrassing…
Kompas
1
quote:

Leefloon schreef op 10 maart 2023 11:56:

Dinsdag KV.
Kunnen we niet meer van die KV's krijgen? Koers loopt voorlopig lekker terug op ;-)
Warrige Buffel
0
Gisteren tikte de koers ook 3.37 aan op laag volume om daarna in een klein uur naar 2.93 te gaan op hoog volume.
Leefloon
3
quote:

Kompas schreef op 14 maart 2023 09:42:

Kunnen we niet meer van die KV's krijgen? Koers loopt voorlopig lekker terug op ;-)
Aan KV's geen gebrek: live.euronext.com/nl/resources/notice...

Koersen terug bij af komt vaker voor bij een zeer hoge, richtingneutrale volatiliteit. Ook daaraan dezer dagen geen gebrek.
Sigaar en whisky
0
FC de kampioenen moet nu echt de duimen leggen… want geen grotere soap dan deze.

Het aantal uitstaande aandelen, de perspectieven, de intrinsieke waarde… What a mess.
Down-up
0
Wederom een klein half-miljoeneke aandelekes erbij! T’is een gewoonte aan’t worden….

14-03-2023 PRESS RELEASE Regulated information
Conversion of a portion of the Highbridge/Whitebox loans Information on the total number of voting rights (denominator)
Liege, Belgium, 14 March 2023 – 17:45 CET – Mithra Pharmaceuticals SA (Euronext Brussels: MITRA) (the "Company" or "Mithra"), a company dedicated to Women’s Health, today announces that, following the first and second drawdowns by the Company under the loan facility concluded with funds managed by Highbridge Capital Management, LLC ("Highbridge") and funds managed by Whitebox Advisors, LLC ("Whitebox", and together with Highbridge, each a “Lender”), another portion of the loans was contributed in kind by Highbridge against the issuance of new shares.
On 8th August 2022, the Company and the Lenders entered into a three-year term senior secured convertible facilities agreement for an amount of up to EUR 100 million, which can be drawn in three tranches. The first tranche of EUR 50 million was drawn upon signing of the agreement; the second tranche of EUR 25 million was drawn on 31st October 2022.
Following the first and second drawdowns, another portion of the loans (including accrued interest, as relevant, and an option payment amount) was contributed in kind for an aggregate amount of EUR 1,854,570.72 through the issuance of 482,528 new shares at an issue price of ca. EUR 3.84 per share. Following the last contribution in kind, the outstanding principal amount of the loans already drawn is EUR 48,860,161.29.
In accordance with article 15 of the Belgian Act of 2 May 2007 on the disclosure of major participations in issuers of which shares are admitted to trading on a regulated market and regarding miscellaneous provisions, following this capital increase’s completion Mithra now has 57,073,622 outstanding shares carrying voting rights (against 56,591,094 outstanding shares carrying voting rights previously).
Therefore, Mithra publishes the following updated information:
• Capital: EUR 41.783.378,35
• Total number of securities carrying voting rights: 57,073,622 (all ordinary shares)
• Total number of voting rights (= denominator): 57,073,622 (all relating to ordinary shares)
• Number of outstanding rights to subscribe to securities carrying voting rights:
o Pursuant to the share option plan of 5 November 2018: 1,394,900 subscription rights giving right to 1,394,900 ordinary shares
o Pursuant to the warrant plan of 22 July 2020: 690,000 subscription rights giving right to 720,571 ordinary shares
o Pursuant to the warrant plan of 7 September 2020: 300,000 subscription rights giving right to 313,292 ordinary shares
o Pursuant to the share option plan of 20 November 2020: 390,717 subscription rights giving rise to 390,717 ordinary shares
FORT1944
0
quote:

Sigaar en Cognac schreef op 14 maart 2023 22:05:

FC de kampioenen moet nu echt de duimen leggen… want geen grotere soap dan deze.

Het aantal uitstaande aandelen, de perspectieven, de intrinsieke waarde… What a mess.
er bestaan nog andere praatbarakken waar ge terecht kunt met Uw prietpraat maar verdoet hier niet langer Uw tijd:)
Biokloot
0
Ja lap , weer wat prietpraat voor de realisten : Conversion of a portion of the Highbridge/Whitebox loans
Information on the total number of voting rights (denominator)

Liege, Belgium, 14 March 2023 – 17:45 CET – Mithra Pharmaceuticals SA (Euronext Brussels: MITRA) (the "Company" or "Mithra"), a company dedicated to Women’s Health, today announces that, following the first and second drawdowns by the Company under the loan facility concluded with funds managed by Highbridge Capital Management, LLC ("Highbridge") and funds managed by Whitebox Advisors, LLC ("Whitebox", and together with Highbridge, each a “Lender”), another portion of the loans was contributed in kind by Highbridge against the issuance of new shares.

On 8th August 2022, the Company and the Lenders entered into a three-year term senior secured convertible facilities agreement for an amount of up to EUR 100 million, which can be drawn in three tranches. The first tranche of EUR 50 million was drawn upon signing of the agreement; the second tranche of EUR 25 million was drawn on 31st October 2022.

Following the first and second drawdowns, another portion of the loans (including accrued interest, as relevant, and an option payment amount) was contributed in kind for an aggregate amount of EUR 1,854,570.72 through the issuance of 482,528 new shares at an issue price of ca. EUR 3.84 per share. Following the last contribution in kind, the outstanding principal amount of the loans already drawn is EUR 48,860,161.29.
Larsi!
0
quote:

Biokloot schreef op 15 maart 2023 06:54:

Er staan weer mooie blokjes klaar om te dumpen ....
Ik pik ze met veel plezier op!
Biokloot
0
François Fornieri, de hoofdaandeelhouder van het farmabedrijf Mithra, moet voor de Luikse strafrechter komen in de zaak rond mogelijke handel met voorkennis in Mithra-aandelen.

Lees meer op: beursig.com/forum/viewtopic.php?f=4&a... voor meer informatie
2.416 Posts, Pagina: « 1 2 3 4 5 6 ... 32 33 34 35 36 37 38 39 40 41 42 ... 117 118 119 120 121 » | Laatste
Aantal posts per pagina:  20 50 100 | Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met uw e-mailadres en wachtwoord.

Direct naar Forum

Detail

Vertraagd 4 mrt 2024 09:09
Koers 0,515
Verschil -0,011 (-2,09%)
Hoog 0,546
Laag 0,512
Volume 59.503
Volume gemiddeld 237.400
Volume gisteren 178.726

EU stocks, real time, by Cboe Europe Ltd.; Other, Euronext & US stocks by NYSE & Cboe BZX Exchange, 15 min. delayed
#/^ Index indications calculated real time, zie disclaimer, streaming powered by: Infront